Back to search

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

Data up to Jan 2025

Published1988
Citations848
References27

Total Citations Per Year

Abstract

References (27)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Beta blockade during and after myocardial infarction: An overview of the randomized trials

1985 • 3,248 citations

EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

1986 • 2,315 citations

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1987 • 2,245 citations

Secondary prevention of vascular disease by prolonged antiplatelet treatment

1988 • 962 citations

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

1985 • 756 citations

Stein's Paradox in Statistics

1977 • 734 citations

A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)

1986 • 705 citations

Why do we need some large, simple randomized trials?

1984 • 692 citations

Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction

1987 • 628 citations

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1985 • 578 citations

Thrombolytic Therapy: Current Status

1988 • 556 citations

Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1

1987 • 504 citations

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.

1988 • 441 citations

Clinical pharmacology of platelet cyclooxygenase inhibition.

1985 • 432 citations

United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results

1988 • 374 citations

Intravenous short-term infusion of streptokinase in acute myocardial infarction.

1983 • 368 citations

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.

1988 • 246 citations

Thrombolytic Therapy

1984 • 208 citations

Allocation of patients to treatment groups in a controlled clinical study

1978 • 190 citations

EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL

1988 • 167 citations

Clinical trial methodology

1978 • 106 citations

Cumulative antiplatelet effect of low‐dose enteric coated aspirin

1985 • 100 citations

Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction

1987 • 82 citations

Anaphylactic Reactivity to Streptokinase

1984 • 60 citations

A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.

1979 • 50 citations

Potential time saving with pre-hospital intervention in acute myocardial infarction

1988 • 31 citations

Cited By (0)

No citing papers found in database

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17… (1988) – The Lancet | Metascience Observatory Explorer